A carregar...

Analysis of participant withdrawal in Huntington disease clinical trials

BACKGROUND: Excellent retention in Huntington disease (HD) clinical trials is essential for testing new therapies. The stage of disease, cognitive status, and availability of a care partner may influence retention in HD clinical trials. OBJECTIVE: We sought to analyze reasons for early withdrawal in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Huntingtons Dis
Main Authors: Banno, Haruhiko, Andrzejewski, Kelly L., McDermott, Michael P., Murphy, Alyssa, Majumder, Madhurima, de Blieck, Elisabeth A., Auinger, Peggy, Cudkowicz, Merit E., Atassi, Nazem
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5565148/
https://ncbi.nlm.nih.gov/pubmed/28671136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JHD-170246
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!